Pooled-Analysis Of 54 Clinical Studies Shows No Increased Risk Of Heart Attack With Abacavir Therapy

August 12th, 2008 by

admin

GlaxoSmithKline (NYSE: GSK) (GSK) declared that a analyse of accumulation from over 14,600 patients in 54 clinical studies showed no accumulated venture of myocardial pathology related with the anti-HIV drug abacavir.

Tags: Heart, Hiv, Led, NCR, Risk

Posted in Cardiology |

Related posts

Comments are closed.

Recent Posts

To Floss or Not to Floss?
Black, Less-Educated Women Less Likely To Undergo Breast Reconstruction Surgery After Mastectomy, Study Finds
Physicians Coalition For Injectable Safety Warns Consumers About Cosmetic Injection Discounts
Cosmetic Patients: Are We Meeting Cosmetic Patients’Needs? Providing Optimal Satisfaction In Facial Rejuvenation
65-Year Old Gunshot Victim Received Complex Procedure To Avoid Life-Threatening Ulcers
Plastic Surgeons Warn Of Malnutrition In Body Contouring Patients
Are the adverse effects of glitazones linked to induced testosterone deficiency?
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects
Metabolic syndrome according to different definitions in a rapidly developing country of the African region

Categories

Archives:

Search: